Kensuke Nakamura

Kensuke Nakamura

Auto-generated profile, based on publicly available information

Kensuke Nakamura

Laboratory of Veterinary Internal Medicine, Department of Veterinary Clinical Sciences, Graduate School of Veterinary Medicine, Hokkaido University, N18 W9, Sapporo, Hokkaido 060-0818, Japan

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2010 in Veterinary Radiology & Ultrasound
Verified
Journal Article
Closed access
PDF file
KNKensuke Nakamura
Kensuke Nakamura
STSatoshi Takagi
Satoshi Takagi
NSNoboru Sasaki
Noboru Sasaki
WKWickramasekara Rajapakshage Bandula Kumara
Wickramasekara Rajapakshage Bandula Kumara
MMMasahiro Murakami
Masahiro Murakami
MTMitsuyoshi Takiguchi
Mitsuyoshi Takiguchi

18 October 2014 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
PDF file
KNK. Nakamura
K. Nakamura
TOT. Osuga
T. Osuga
KMK. Morishita
K. Morishita
SSS. Suzuki
S. Suzuki
TMT. Morita
T. Morita
MTMitsuyoshi Takiguchi
Mitsuyoshi Takiguchi
Background A strong correlation between left atrial (LA) dysfunction and the severity of cardiac disease has been described in human patients with various cardiac diseases. The role of LA dysfunction in dogs with chronic mitral valvular heart disease (CMVHD) has not been addressed. Objectives To investigate the correlation between LA function and the prognosis of dogs with CMVHD. Animals Thirty‐eight client‐owned dogs with CMVHD. Methods Prospective clinical cohort study. Dogs were divided into 2 groups (survivors and nonsurvivors) based on the onset of cardiac‐related death within 1 year. Physical examination and echocardiographic variables were compared between the groups. For the assessment of the comparative accuracy in identifying patients with cardiac‐related death, receiver operating characteristic (ROC) curves and multivariate logistic analysis were used. Results The highest accuracy was obtained for the LA active fractional area change (LA‐FACact), with an area under the ROC curve (AUC) of 0.95, followed by the left atrial to aortic root ratio (LA/Ao), with an AUC of 0.94; peak early diastolic mitral inflow velocity (E), with an AUC of 0.85; and LA total fractional area change (LA‐FACtotal), with an AUC of 0.85. In the multivariate logistic regression analysis, LA‐FACact emerged as the only independent correlate of cardiac‐related death within 1 year (odds ratio = 1.401, P = .002). Conclusions and Clinical Importance Regarding both the size and function, the LA has a strong correlation with the prognosis of dogs with CMVHD. The most significant independent predictor of mortality in this study was LA‐FACact.

11 January 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
OIOsamu Ichii
Osamu Ichii
HOHiroshi Ohta
Hiroshi Ohta
THTaro Horino
Taro Horino
TNTeppi Nakamura
Teppi Nakamura
MHMarina Hosotani
Marina Hosotani
YKYasuhiro Kon
Yasuhiro Kon
MicroRNAs act as post-transcriptional regulators, and urinary exosome (UExo)-derived microRNAs may be used as biomarkers. Herein, we screened for UExo-derived microRNAs reflecting kidney disease (KD) status in dogs. Examined dogs were divided into healthy kidney control (HC) and KD groups according to renal dysfunction. We confirmed the appearance of UExo having irregular globe-shapes in a dog by immunoblot detection of the exosome markers, TSG101 and CD9. Based on our previous data using KD model mice and the data obtained herein by next generation sequencing of UExo-derived microRNAs in dogs, miR-26a, miR-146a, miR-486, miR-21a, and miR-10a/b were selected as candidate microRNAs. In particular, UExo-derived miR-26a and miR-10a/b were significantly decreased in KD dogs, and miR-26a levels negatively correlated with deteriorated renal function compared to the other miRNAs. UExo-derived miR-21a levels corrected or not to that of internal control microRNAs in UExo, miR-26a and miR-191, significantly increased with renal dysfunction. In kidney tissues, the decrease of miR-26a and miR-10a/b in the glomerulus and miR-10b in the tubulointerstitium negatively correlated with deteriorated renal function and histopathology. Increased miR-21a in the tubulointerstitium rather than in the glomerulus correlated with deteriorated renal histopathology. In conclusion, microRNAs reflecting the changes in renal function and histopathology in dogs were identified in this study.

1 January 2010 in Journal of Veterinary Medical Science
Verified
Journal Article
Open access
PDF file
SHShiang-Jyi Hwang
Shiang-Jyi Hwang
MYMasahiro Yamasaki
Masahiro Yamasaki
KNKensuke Nakamura
Kensuke Nakamura
NSNoboru Sasaki
Noboru Sasaki
MMMasahiro Murakami
Masahiro Murakami
MTMitsuyoshi Takiguchi
Mitsuyoshi Takiguchi
We attempted to develop a strain of Babesia gibsoni resistant to diminazene aceturate (DA), an anti-babesial drug, in vitro. Since the DA-sensitive B. gibsoni strain could survive and proliferate in culture medium containing 1 ng/m l DA, the concentration of DA was gradually increased from 1 to 200 ng/ml. The results showed that the parasites could survive and proliferate in the medium containing 200 ng/m l DA, which was much higher than the 50% inhibitory concentration (IC50) of DA for B. gibsoni. Subsequently, these parasites were removed from erythrocytes and exposed directly to 200 ng/ml DA. They were able to survive and invade fresh erythrocytes, though the DA-sensitive B. gibsoni strain did not survive. Based on these results, the parasites cultured within 200 ng/ml DA were determined to be a DA-resistant B. gibsoni strain. In addition, the IC50 levels of clindamycin, doxycycline and pentamidine for the DA-resistant B. gibsoni strain were determined. The IC50 levels of clindamycin, doxycycline and pentamidine for the DA-resistant strain were higher than those for the DA-sensitive strain. The IC50 of pentamidine for the resistant strain was much greater than that for the DA-sensitive strain. These results indicated that the DA-resistant B. gibsoni strain could have resistance not only to DA, but also to other anti-babesial drugs. In conclusion, we successfully developed a DA-resistant B. gibsoni strain in vitro.

16 April 2018 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
PDF file
YHYasutomo Hori
Yasutomo Hori
MIMasayuki Iguchi
Masayuki Iguchi
YHYasuhiro Heishima
Yasuhiro Heishima
YYYohei Yamashita
Yohei Yamashita
KNKensuke Nakamura
Kensuke Nakamura
SUSyuhei Uchida
Syuhei Uchida
Background: Cardiac troponin I (cTnI) is useful for assessing hypertrophic cardiomyopathy (HCM) in cats. Objective: To measure plasma cTnI concentrations in healthy cats and evaluate the clinical utility of cTnI in determining the severity of HCM. Animals: Clinically healthy cats (n = 88) and cats with HCM (n = 93). Methods: Multicenter prospective study. Cats with HCM, including hypertrophic obstructive cardiomyopathy at various stages, were diagnosed using echocardiography. Plasma cTnI concentrations were analyzed by a commercial laboratory. Receiver-operating characteristic curve analysis was used to evaluate the accuracy of plasma cTnI concentrations to detect HCM. Results: The median cTnI concentration was 0.027 ng/mL (interquartile range, 0.012-0.048 ng/mL) in healthy cats. Concentrations were significantly higher in diseased cats than in healthy controls, and concentrations were significantly higher in cats with heart failure than in asymptomatic cats. A plasma cTnI concentration of 0.163 ng/mL had a sensitivity of 62.0% and specificity of 100% when used to distinguish normal cats from asymptomatic HCM cats without left atrial dilatation. A cutoff of 0.234 ng/mL had high sensitivity (95.0%) and specificity (77.8%) for assessing heart failure. The areas under the receiver-operating characteristic curves were 0.85 and 0.93, respectively. Conclusions and Clinical Importance: Increased cTnI concentrations reflect the severity of HCM. If other causes of cardiac injury are ruled out, plasma cTnI concentration may be useful for predicting the severity of HCM in cats.

8 May 2017 in New Zealand Veterinary Journal
Verified
Journal Article
Closed access
AMA Matsuyama
A Matsuyama
STS Takagi
S Takagi
KHK Hosoya
K Hosoya
YKY Kagawa
Y Kagawa
KNK Nakamura
K Nakamura
MTM Takiguchi
M Takiguchi
To compare the survival of dogs with completely resected massive hepatocellular carcinoma (HCC) with that of dogs in which HCC were incompletely excised. A retrospective cohort study was conducted. Dogs that underwent surgical excision of massive HCC between November 2006 and April 2015 were included. Dogs that died in the perioperative period or were lost to follow-up within 2 months after surgery were excluded. Data were collected from the medical records and a single pathologist examined all available histology slides to confirm the diagnosis of HCC. Surgical margins were defined as complete if no neoplastic cells were seen at the edge of excised tissues, based on original histopathology reports. Progression-free survival (PFS) and overall survival (OS) were compared between dogs with complete surgical margins (CM) and those with incomplete margins (IM) using a log-rank test. Of the 37 dogs included in the study, 25 were allocated to the CM group and 12 to the IM group. Progressive local disease developed after surgery in three dogs in the CM group and seven dogs in the IM group. Three dogs in the CM group and five dogs in the IM group died due to tumour progression. Median PFS was longer for dogs in the CM group (1,000 (95% CI=562-1,438) days) compared to dogs in the IM group (521 (95% CI=243-799) days; p=0.007). OS was also longer for dogs in the CM group (>1,836 days) compared to those in the IM group (median 765 (95% CI=474-1,056) days; p=0.02). Compared with complete resection, incomplete resection decreased PFS and OS in dogs with massive HCC. Dogs with incompletely excised HCC should be closely monitored for local recurrence, although median OS was >2 years following incomplete excision. Further prospective studies are warranted to confirm these findings.